van Deelen R A J, Rommers M K, Eerenberg J G, Egberts A C G
Afd. Geriatrie, TweeSteden Ziekenhuis, Postbus 90.107, 5000 LA Tilburg.
Ned Tijdschr Geneeskd. 2002 Nov 2;146(44):2095-8.
A 71-year-old single male who was being treated for Parkinson's disease with levodopa, had several episodes of hypersexual behaviour. Home care was terminated for this reason. Family members in particular had problems with his behaviour. It transpired that he was taking more levodopa than prescribed. After explaining the side-effect to the patient and after a special medication box was purchased which could be filled by the family, the patient's hypersexuality disappeared without deterioration of Parkinson's disease. Hypersexuality is a known, though not frequently recognised side-effect of dopaminergic anti-Parkinson therapy, especially levodopa. This side-effect is not life-threatening, but can have an enormous impact on the quality of life of the patient, his or her partner and environment. The mechanism is probably related to the pharmacological action of dopamine.
一名71岁的单身男性正在接受左旋多巴治疗帕金森病,出现了几次性欲亢进行为。为此,家庭护理被终止。特别是家庭成员对他的行为感到困扰。结果发现他服用的左旋多巴超过了规定剂量。在向患者解释了这种副作用并购买了一个可由家人装药的特殊药盒后,患者的性欲亢进消失了,帕金森病也没有恶化。性欲亢进是多巴胺能抗帕金森治疗(尤其是左旋多巴)已知的副作用,尽管并不经常被认识到。这种副作用不会危及生命,但会对患者及其伴侣和周围环境的生活质量产生巨大影响。其机制可能与多巴胺的药理作用有关。